Sandy Draper
Stock Analyst at Guggenheim
(2.94)
# 1,428
Out of 4,832 analysts
119
Total ratings
58.33%
Success rate
19.74%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $310.15 | +39.29% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $150.68 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $144.02 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $9.27 | +266.77% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.30 | +132.56% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $60.43 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.65 | -24.53% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $140.49 | +87.20% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $2.70 | +1,011.11% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $96.99 | -3.08% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.62 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $24.30 | +109.92% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $152.28 | -15.29% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $29.31 | +87.65% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $53.67 | +213.02% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $64.00 | -81.25% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $22.87 | +66.19% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.14 | +872.76% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $8.36 | +677.51% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $4.29 | +739.16% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $241.20 | -30.76% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.53 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $16.94 | +271.90% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $310.15
Upside: +39.29%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $150.68
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $144.02
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $9.27
Upside: +266.77%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.30
Upside: +132.56%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $60.43
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.65
Upside: -24.53%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $140.49
Upside: +87.20%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $2.70
Upside: +1,011.11%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $96.99
Upside: -3.08%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.62
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $24.30
Upside: +109.92%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $152.28
Upside: -15.29%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $29.31
Upside: +87.65%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $53.67
Upside: +213.02%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $64.00
Upside: -81.25%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $22.87
Upside: +66.19%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.14
Upside: +872.76%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $8.36
Upside: +677.51%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $4.29
Upside: +739.16%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $241.20
Upside: -30.76%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.53
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $16.94
Upside: +271.90%